title: Hydroxyethyl starch 130/0.4 or hypertonic saline solution to decrease inflammatory response in hemorrhagic shock?
authors.forename: Pierre
authors.initials: P
authors.lastname: Esnault
authors.forename: Bertrand
authors.initials: B
authors.lastname: Prunet
authors.forename: Jean
authors.initials: J
authors.lastname: Cotte
authors.forename: Pierre-Julien
authors.initials: PJ
authors.lastname: Cungi
authors.forename: Audrey
authors.initials: A
authors.lastname: Alonso
authors.forename: Ambroise
authors.initials: A
authors.lastname: Montcriol
mesh_terms: D000818:Animals; D005780:Gelatin / Q000627:therapeutic use*; D006895:Hydroxyethyl Starch Derivatives / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D007249:Inflammation / Q000378:metabolism*; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects*; D012771:Shock, Hemorrhagic / Q000188:drug therapy* / Q000378:metabolism*; D013386:Succinates / Q000627:therapeutic use*
chemical_list: D006895:Hydroxyethyl Starch Derivatives; D013386:Succinates; D005780:Gelatin